Simultaneous Determination of Epinephrine, Noradrenaline and Dopamine in Human Serum Samples by High Performance Liquid Chromatography with Chemiluminescence Detection

A simple, rapid and accurate high performance liquid chromatographic （HPLC） technique coupled with chemiluminescence （CL） detection was developed for the simultaneous determination of epinephrine （E）, noradrenaline （NA） and dopamine （DA）. It was based on the analyte enhancement effect on the CL reaction between luminol and potassium ferricyanide. The effects of various parameters, such as potassium ferricyanide concentration, luminol concentration, pH value and component of the mobile phase on chromatographic behaviors of the analytes （E, NA and DA） were investigated. The separation was carded out on C18 column using the mobile phase of 0.01 mol/L potassium hydrogen phthalate solution and methanol （92 ： 8, V/V）. Under the optimum condi- tions, E, NA and DA showed good linear relationships in the range of 1 × 10^-8 -5 × 10^-6, 5.0× 10^-9 -1.0× 10^-6 and 5.0×10^-9-1.0× 10^-6 g]mL respectively. The detection limits for E, NA and DA were 4.0×10^-9, 1.0× 10^-9 and 8.0 × 10^-10 g/mL. The proposed method has been applied successfully to the analysis of E, NA and DA in human serum samples.     

Determination of Abacavir, Lamivudine and Zidovudine in Pharmaceutical Tablets, Human Serum and in Drug Dissolution Studies by HPLC

A simple, accurate, precise and fully automated method for the simultaneous determination of abacavir, lamivudine and zidovudine in pharmaceutical tablets, human serum samples and drug dissolution studies has been developed. Separation was performed on a 5 μm Zorbax^® C₁₈ column (150 × 4.6 mm ID) with methanol:water:phosphate buffer at pH 5.65 (80:10:10; v/v/v) isocratic elution in less than 7 min with a flow rate of 0.6 mL min^?1.Good sensitivity for all analytes was observed with UV detection at 275 nm. The method allowed quantitation over the 500–3,000 ng mL^?1 range for abacavir and 500–5,000 ng mL^?1 range for lamivudine and zidovudine. The method has been applied, without any interference from excipients or endogenous substances, for the simultaneous determination of these three compounds in tablets. Human serum and drug dissolution studies.     

Determination of Celecoxib, Rofecoxib, Sodium Diclofenac and Niflumic Acid in Human Serum Samples by HPLC with DAD Detection

A reverse-phase high-performance liquid chromatographic method has been developed for the separation and simultaneous determination of two COX-2 inhibitors, celecoxib and rofecoxib, in addition to two well-known non-steroidal anti-inflammatory drugs (NSAIDs), sodium diclofenac and niflumic acid in human serum samples. Good chromatographic separation was achieved using a C18 bonded silica column applying a gradient with acetronitrile and water, from 15 to 60% acetonitrile. The mobile phase contained 0.1% trifluoroacetic acid as an organic modifier. Detection was made using a diode array detector (DAD) and the analytical parameters were established at the wavelength maximum in the UV spectrum of each drug. Linearity was studied up to 100.0 mg L⁻¹. Calibration functions, quantification and detection limits, intra- and inter-day reproducibility and accuracy were estimated for each drug. Solid phase extraction was needed to separate and concentrate the drugs from human serum samples. The method was successfully applied to determine the drugs in human serum samples at levels of 1.0 mg L⁻¹.     

高效液相色谱化学发光检测人体血清及尿样中的盐酸肾上腺素

研究发现,盐酸肾上腺素在碱性条件下能显著增强铁氰化钾-鲁米诺化学发光强度。基于此建立了新的测定肾上腺素的方法。本方法以C18反相键合相为色谱柱,用0.01 mol/L邻苯二甲酸氢钾-甲醇(92∶8,V/V)为流动相,实现了对人体血清及尿样中盐酸肾上腺素的分离与测定。在最适宜条件下,方法的线性范围为10~5000μg/L;检出限为4.0×10-6g/L;相对标准偏差为3.0%(n=11)。     

Simultaneous Determination of Phenolic Acids in Water Caltrop by HPLC-DAD

Trapa natans L., or the water caltrop, a native plant of Romania, has not been researched in our country until recently. It has, however, been used for the treatment of the several diseases since ancient times. The objective of this work is to validate the HPLC method to detect and quantify the phenolic acids from Trapa natans L. specie. The HPLC-DAD method was validated for the analysis of 3-O-methylgallic, chlorogenic, caffeic, and ferulic acids in water caltrop roots, leaves, pulp, and hulls. The analysis was conducted on a Zorbax XDB-C18 column with gradient elution of acetonitrile-orthophosphoric acid. The method was validated in terms of linearity, accuracy, precision, limit of detection, quantification, and recovery, and found to be satisfactory. We verified the performance parameters after experimental studies, and we established that the HPLC method can be applied for the determination of phenolic acids in plant materials.     

毛细管电泳法同时测定血清中的左旋多巴和甲基多巴

建立了毛细管电泳-紫外检测同时测定血清中左旋多巴和甲基多巴的方法。以40 mmol/L硼砂（pH 9.5）为分离缓 冲溶液,在3.45 kPa（0.5 psi）压力下进样7 s、分离电压22 kV、检测波长200 nm、温度25 ℃的条件下进行测定,两 种物质获得了较好的分离。甲基多巴和左旋多巴分别为1.0~64.0 mg/L和1.0~71.0 mg/L时与峰面积呈良好的线性关系, 线性相关系数分别为0.9998和0.9994,检出限分别为0.6和0.8 mg/L(以信噪比为3计)。将该法用于血清中甲基多巴和左 旋多巴的测定,回收率为82.8%~88.8%,相对标准偏差为2.10%~2.63%。     

Development and Validation of an RP-HPLC Method for Determination of Valganciclovir in Human Serum and Tablets

This paper describes the validation of an isocratic high-performance liquid chromatographic method for the assay of valganciclovir in raw materials, tablets and human serum samples. Valganciclovir and fluvastatin (internal standard) were well separated using a reversed phase column and a mobile phase consisting of a mixture of acetonitrile:methanol:KH₂PO₄ (0.02 M) (40:20:40; v/v/v) (at pH 5.0). The mobile phase was pumped at 1.0 mL min⁻¹ flow rate and valganciclovir was detected by diode-array detection at 255 nm. The retention times for valganciclovir and fluvastatin were 3.41 and 5.60 min, respectively. A linear response (r > 0.999) was observed in the range of 10–30,000 ng mL⁻¹ in mobile phase and serum. The limit of detection and limit of quantification were found as 2.95 and 9.82 ng mL⁻¹ in mobile phase and 1.73 and 5.77 ng mL⁻¹ in human serum samples, respectively. Validation parameters as precision, accuracy, selectivity, reproducibility and system suitability tests were also determined. The method can be used for valganciclovir assay of tablets and human serum samples as the method separates valganciclovir from tablet excipients and endogenous substances.

     

Simultaneous Determination of Pyridoxine,Meclizine and Buclizine in Dosage Formulations and Human Serum by RP-LC

Rapid liquid chromatographic procedures for analytical quality control of pharmaceutical preparations and human serum containing antihistamine drugs, meclizine and buclizine alone or in combination with pyridoxine are proposed, using acetonitrile:water (80:20) as a mobile phase (pH adjusted to 2.6), methylparaben as internal standard and UV detection was made at 230 nm. The results obtained showed a good agreement with the declared content. The method shows good linearity in the range of 30–10,000 ng mL⁻¹ for pyridoxine and 25–10,000 ng mL⁻¹ for meclizine and buclizine serum concentrations with a correlation coefficient 0.9999 (inter- and intra-day CV < 3.91%). The recovery was >97.8%. The proposed method may be used for the quantitative analysis of meclizine and buclizine alone or in combination with pyridoxine from raw materials, in bulk drugs, dosage formulations and in serum.

     

Simultaneous Determination of Pyridoxine, Meclizine and Buclizine in Dosage Formulations and Human Serum by RP-LC

Rapid liquid chromatographic procedures for analytical quality control of pharmaceutical preparations and human serum containing antihistamine drugs, meclizine and buclizine alone or in combination with pyridoxine are proposed, using acetonitrile:water (80:20) as a mobile phase (pH adjusted to 2.6), methylparaben as internal standard and UV detection was made at 230 nm. The results obtained showed a good agreement with the declared content. The method shows good linearity in the range of 30–10,000 ng mL^?1 for pyridoxine and 25–10,000 ng mL^?1 for meclizine and buclizine serum concentrations with a correlation coefficient 0.9999 (inter- and intra-day CV < 3.91%). The recovery was >97.8%. The proposed method may be used for the quantitative analysis of meclizine and buclizine alone or in combination with pyridoxine from raw materials, in bulk drugs, dosage formulations and in serum.     

Simultaneous Determination of Calcium and Magnesium in Human Blood Serum by Atomic Absorption Spectrophotometer

Abstract

Simultaneous determination of calcium and magnesium content in human blood serum has been reported as a routine clinical laboratory method, which is rapid, simple, and requires 50 δ of serum for complete analysis with triplicate runs. This is accomplished using a Model 1250 Varian Techtron Atomic Absorption Spectrophotometer with the stoichiometric nitrous oxide-acetylene flame of 0.2 cm red-cone height. Calcium and magnesium standards and also the serum specimens are prepared in aqueous medium containing 2000 ppm potassium chloride. Serum specimens are ultimately diluted to 1:100 fold. About 40–50 samples can be analyzed per hour of instrument operation, if standard solutions and diluted serum specimens are readily available.     

Simultaneous Determination of Lidocaine, Proline and Lomefloxacin in Human Urine by CE with Electrochemiluminescence Detection

A new method was developed for the simultaneous determination of lidocaine, proline and lomefloxacin in human urine by capillary electrophoresis-electrochemiluminescence detection with Ru(bpy)₃ ²⁺. Conditions of the separation and detection were investigated and optimized. It was proved that 20 mM phosphate buffer at pH 6.7 could achieve the most favorable resolution, and the high sensitivity of detection was obtained by using the detection potential at 1.15 V and 5 mM Ru(bpy)₃ ²⁺–60 mM phosphate buffer at pH 7.6 in the detection reservoir. The detection limits were 0.02 μg mL⁻¹ for lidocaine, 0.03 μg mL⁻¹ for proline and 0.06 μg mL⁻¹ for lomefloxacin. Relative standard deviations of the ECL intensity and the migration time were 3.5 and 1.1% for 6 μg mL⁻¹ lidocaine, 3.2 and 1.0% for 6 μg mL⁻¹ proline and 3.7 and 1.2% for 6 μg mL⁻¹ lomefloxacin, respectively. A baseline separation for lidocaine, proline and lomefloxacin was achieved within 360 s. The developed method was successfully applied to determine the amounts of lidocaine, proline and lomefloxacin in human urine. The recovery and RSD were in the range of 93.3–97.2 and 3.8–4.9%, respectively.     

The Rapid Determination of Neopterine in Human Urine by Isocratic High-Performance Liquid Chromatography

Abstract

An isocratic high-performance liquid chromatography method is described for the determination of Neopterine eliminated in human urine, using a μ-Bondapak C₁₈ column (300 × 3.9 mm I.D.) and a strongly polar phosphate buffer (pH 6.2) for elution. This analysis requires only 15 minutes and allows very good reproduc-tibility of retention times. This method is well-suited for automation and routine clinical laboratory in order to quantify human urinary Neopterine in healthy subjects and in subjects with malignant disorders.     

Determination of Ketorolac Tromethamine in Human Eye Samples by HPLC with Photo Diode-Array Detection

A sensitive and selective reversed-phase HPLC method for analysis of ketorolac in aqueous and vitreous humor from the human eye has been developed and validated. Chromatographic separation was achieved on a 250 mm × 4.6 mm i.d., 5-μm particle, C₁₈ analytical column. Photo diode-array detection was performed at 314 nm. Response was a linear function of ketorolac concentration from 10 to 800 ng mL⁻¹. The limits of detection (LOD) and quantification (LOQ) were 3.0 and 10 ng mL⁻¹, respectively. Intra-day and inter-day bias were less than 2.05 and 2.28%, respectively, and intra-day and inter-day RSD were no higher than 3.60 and 5.80%, respectively. Fluid obtained from patients eyes’ after topical application of Acular eye drops before retina decolman surgery was analyzed by use of the method. The method enabled successful quantification of levels of ketorolac in aqueous and vitreous humor.

     

Simultaneous Determination of Safingol and d-erythro-Sphinganine in Human Plasma by LC with Fluorescence Detection

l-threo-Sphinganine (safingol) is a putative synthetic sphingosine kinase inhibitor currently being tested in clinical trials as an anticancer agent. To enable defining the pharmacokinetic properties of safingol in humans, we developed a sensitive analytical method to simultaneously quantitate safingol and its naturally-occurring diastereomer, d-erythro-sphinganine in human plasma. Of the two different fluorogenic derivatization agents (NDA and OPA) and several pH conditions compared for the derivatization, we found that NDA derivatization achieved more than 20 times greater sensitivity compared with OPA derivatization, and pH 9.0 showed the highest sensitivity for both compounds. An analytical method for liquid chromatography (LC) with a fluorescence detector (FLD) was developed and validated with calibration curve ranges of 20–1,000 ng mL⁻¹ for safingol and d-erythro-sphinganine. Our LC-FLD method using NDA-derivatization enabled simultaneous quantification of safingol and its naturally-occurring diastereomer, d-erythro-sphinganine with satisfactory sensitivity in human plasma.

     

Simultaneous Determination of Safingol and d-erythro-Sphinganine in Human Plasma by LC with Fluorescence Detection

l-threo-Sphinganine (safingol) is a putative synthetic sphingosine kinase inhibitor currently being tested in clinical trials as an anticancer agent. To enable defining the pharmacokinetic properties of safingol in humans, we developed a sensitive analytical method to simultaneously quantitate safingol and its naturally-occurring diastereomer, d-erythro-sphinganine in human plasma. Of the two different fluorogenic derivatization agents (NDA and OPA) and several pH conditions compared for the derivatization, we found that NDA derivatization achieved more than 20 times greater sensitivity compared with OPA derivatization, and pH 9.0 showed the highest sensitivity for both compounds. An analytical method for liquid chromatography (LC) with a fluorescence detector (FLD) was developed and validated with calibration curve ranges of 20–1,000 ng mL^?1 for safingol and d-erythro-sphinganine. Our LC-FLD method using NDA-derivatization enabled simultaneous quantification of safingol and its naturally-occurring diastereomer, d-erythro-sphinganine with satisfactory sensitivity in human plasma.     

Simultaneous Determination of Neuroactive Amino Acids in Serum by CZE Coupled with Amperometric Detection

A quantitative determination of six neuroactive amino acids (NAAs) was performed by capillary zone electrophoresis with amperometric detection (CZE-AD). This CZE-AD method utilized two electrolytes: the borate solution flowing in a capillary has the NAAs-separation effects, and the sodium hydroxide (NaOH) solution filled in the detection reservoir for the amperometric analysis of NAAs. The following experimental parameters were optimized: the working electrode potential, the pH value, the component, and the concentration of running buffer, the separation voltage, and the injection time on CZE-AD. Then, under the optimum conditions, the six NAAs could be completely separated in 30 min and had well-shaped AD responses at 0.75 V (versus SCE) on a copper electrode. The linear calibration range of NAAs was from 5 × 10^?4 to 5 × 10^?6 mol L^?1 with the limits of detection (LODs) ranging from 10^?6 to 10^?7 mol L^?1 (signal-to-noise ratio = 3), and the relative standard deviations (RSDs) of the migration time and peak area were 0.45–0.55 and 3.8–6.3 %, respectively. Moreover, this method has succeeded in human serum analysis, and the determined contents of the six NAAs in human serum were in an average recovery range of 85.3–117.9 %, which confirmed the validity and practicability of this method.     

Simultaneous Determination of Tranexamic Acid and Losartan Potassium in Dosage Formulations and Human Serum by RP-LC

Rapid liquid chromatographic procedure for analytical quality control of pharmaceutical preparations and human serum containing drugs, tranexamic acid together with losartan potassium are proposed, using acetonitrile: water (50:50), adjusting pH to 2.6 with phosphoric acid as a mobile phase, UV detection at 205 nm and propylparaben sodium was used as internal standard. The results obtained showed a good agreement with the declared contents. The method shows good linearity in the range of 40–10,000 ng mL^?1 for tranexamic acid serum concentrations with a correlation coefficient 0.9999 (inter- and intra-day CV <3.18) and in the range 5–10,000 ng mL^?1 for losartan potassium serum concentrations with a correlation coefficient 0.9999 (inter- and intra-day CV <3.61). The recovery was >97.8%. The proposed method may be used for the quantitative analysis of tranexamic acid and losartan potassium alone or in combination from raw materials, in bulk drugs, dosage formulations and in serum.     

阴离子交换色谱-荧光检测法测定人体血清中酪氨酸及其代谢产物

建立了阴离子交换色谱-荧光检测法(AEC-FLD)同时测定人体血清中的酪氨酸(Tyr)、对羟苯基乳酸(PHPLA)和对羟苯基丙酸(PHPA)的分析新方法。样品经乙腈处理沉淀蛋白,离心后取上清液直接进样检测。采用IonPac AG21保护柱(50×2mm)、IonPac AS21分析柱(250×2mm),流动相为4mmol/L NaOH溶液,流速为0.45mL/min,荧光检测器的激发波长和发射波长分别为277nm和340nm。优化条件下三种物质能得到良好的分离和检测。Tyr、PHPLA和PHPA的线性范围分别为0.30~25mg/L、0.025~2mg/L和0.025~2mg/L,相关系数在0.9998~0.9999之间,检出限(S/N=3)分别为0.024mg/L、0.020mg/L和0.019mg/L。三个水平的加标回收率在72.6%~99.1%之间,其相对标准偏差均小于6.62%。该方法简单、快速、准确,可用于实际样品的测定。     

超高效液相色谱-串联质谱法同时检测人血清中4种内源性皮质激素

为建立人血清中醛固酮(ALD)、皮质醇(F)、皮质酮(CORT)、可的松(COR)4种内源性皮质激素的快速分析方法,该文首先对样品前处理方法进行优化,以0.3 mol/L硫酸锌溶液结合叔丁基甲基醚对样品进行蛋白沉淀-液液萃取(PPT-LLE)前处理.采用ACQUITY UPLC BEH C18(2.1 mm×100 m...